Results

Total Results: 801 records

Showing results for "described".

  1. www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-primary-care-interventions-for-children-and-adolescents
    May 26, 2020 - Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described
  2. www.uspreventiveservicestaskforce.org/uspstf/recommendation/impaired-visual-acuity-screening-older-adults
    May 24, 2022 - Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described
  3. www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-weight-and-weight-gain-during-pregnancy-behavioral-counseling-interventions
    May 25, 2021 - Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described
  4. www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-adults-with-high-risk-of-cvd
    November 24, 2020 - Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described
  5. untitled (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/y_ApQN4Tw4RtnoWWrofH8d
    December 20, 2016 - Authors followed the policy regarding conflicts of interest described at https://www .uspreventiveservicestaskforce.org
  6. www.uspreventiveservicestaskforce.org/home/getfilebytoken/kqRLYDR2eh3gLKbtTjZk__
    November 30, 2017 - Authors followed the policy regarding conflicts of interest described at https://www .uspreventiveservicestaskforce.org
  7. www.uspreventiveservicestaskforce.org/uspstf/recommendation/child-maltreatment-primary-care-interventions-november-2018
    November 27, 2018 - Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described
  8. www.uspreventiveservicestaskforce.org/uspstf/recommendation/speech-and-language-delay-and-disorders-in-children-age-5-and-younger-screening-july-2015
    July 07, 2015 - Disclosures: Authors followed the policy regarding conflicts of interest described at www.uspreventiveservicestaskforce.org
  9. www.uspreventiveservicestaskforce.org/uspstf/recommendation/preeclampsia-screening-april-2017
    April 25, 2017 - Authors followed the policy regarding conflicts of interest described at http://www.uspreventiveservicestaskforce.org
  10. www.uspreventiveservicestaskforce.org/uspstf/recommendation/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication-january-2017
    January 10, 2017 - Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org
  11. www.uspreventiveservicestaskforce.org/home/getfilebytoken/caCcWa2a6jQGRyb7H8CkbU
    July 01, 2009 - associated with an increased risk for acute visual acuity loss (3 months after the procedure) but, as described
  12. www.uspreventiveservicestaskforce.org/uspstf/document/addendum-to-screening-for-ovarian-cancer-evidence-update-for-the-us-preventive-services-task-force-reaffirmation-recommendation-statement/ovarian-cancer-screening-2012
    April 15, 2012 - Shizuoka Cohort Study of Ovarian Cancer Screening In 2008, Kobayashi et al described the impact of
  13. www.uspreventiveservicestaskforce.org/home/getfilebytoken/QtuWfedsMmUb_sAuKWdsGg
    December 31, 2014 - Shizuoka Cohort Study of Ovarian Cancer Screening In 2008, Kobayashi et al described the impact of
  14. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/vitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication
    April 17, 2018 - or both women and men (3 RCTs). 15-18 The doses and comparators used are similar to what has been described
  15. www.uspreventiveservicestaskforce.org/home/getfilebytoken/Ym2epesCwZWNPaaMr78Shp
    August 01, 2014 - Authors followed the policy regarding conflicts of interest described at www.uspreventive servicestaskforce.org
  16. www.uspreventiveservicestaskforce.org/home/getfilebytoken/oPmYxryXGu2occANaReagc
    August 01, 2022 - Nine RCTs (described in 11 articles) and 1 network meta- analysis assessing harms associated with the … weekly rifapentine plus isoniazid with twice-weekly rifapentine plus isoniazid.134 Four of the RCTs (described … The crite- ria for RCTs to be included in sensitivity analyses were the same as those described for KQ3
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/wKfFrTpC8VtforKLrqGpjQ
    April 18, 2023 - was assessed based on consistency, precision, reporting bias, and study quality, using the approach described
  18. www.uspreventiveservicestaskforce.org/uspstf/recommendation/oral-cancer-screening-1996
    January 01, 1996 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Oral Cancer: Screening, 1996 January 01, 1996 Recommendations made by the USPSTF are independent of the U.S. government. They sh…
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/2Wc3FRHpVDPX2jT_WzjEXX
    July 31, 2020 - Recommended stool-based and direct visualization screening tests are described below. … Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described
  20. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
    March 02, 2020 - in adolescents reported harms, but methods for reporting and assessing harms were generally not well described … Mean follow-up ranged from 1.5 to 10 years in all studies except for 1 study that described follow-up

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: